These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32716315)

  • 21. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
    Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
    Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
    Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
    Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
    Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
    Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
    Sun L; Feng L; Cui J
    Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma.
    Wang C; Dou C; Wang Y; Liu Z; Roberts L; Zheng X
    Int J Biol Sci; 2019; 15(8):1696-1711. PubMed ID: 31360112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway.
    Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J
    J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis.
    Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y
    Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression.
    Wang Z; Sun X; Bao Y; Mo J; Du H; Hu J; Zhang X
    Int J Oncol; 2017 Dec; 51(6):1639-1650. PubMed ID: 29039472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.
    Zhang X; Hu Y; Pan Y; Xiong Y; Zhang Y; Han M; Dong K; Song J; Liang H; Ding Z; Zhang X; Zhu H; Liu Q; Lu X; Feng Y; Chen X; Zhang Z; Zhang B
    Oncogene; 2022 Mar; 41(12):1821-1834. PubMed ID: 35140331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
    Azizi R; Salemi Z; Fallahian F; Aghaei M
    J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
    Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W
    Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
    Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y
    Med Oncol; 2013; 30(3):626. PubMed ID: 23761027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.